Reporting of Palliative Sedation and Use of Opioids at the End of Life in a Belgian University Hospital: A Pilot Study

被引:3
|
作者
Marechal, Nicolas [1 ]
Six, Stefaan [2 ,3 ]
Clemmen, Eveline [4 ]
Baillon, Catherine [4 ]
Tack, Annelien [4 ]
Bauwens, Sabien [4 ]
Noppen, Marc [5 ]
Distelmans, Willem [4 ]
Beyer, Ingo [1 ]
Bilsen, Johan [2 ,3 ]
机构
[1] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Dept Geriatr, Brussels, Belgium
[2] Vrije Univ Brussel, Dept Publ Hlth, Mental Hlth, Brussels, Belgium
[3] Vrije Univ Brussel, Wellbeing Res Grp, Brussels, Belgium
[4] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Dept Support & Palliat Care, Brussels, Belgium
[5] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Board Directors, Brussels, Belgium
关键词
end-of-life decisions; in-hospital mortality; opioids; palliative care; physician intention; CONTINUOUS DEEP SEDATION; EUTHANASIA; CARE;
D O I
10.1089/jpm.2021.0113
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Palliative sedation requires no formal registration in Belgium. For euthanasia, however, there are clear guidelines in certain countries, including mandatory registration and evaluation of cases. Official guidelines have been developed for palliative sedation, but research still shows unskilled use of sedation and unclear demarcation between palliative sedation and euthanasia. Registration could be used to avoid unskilled use of sedation and to avoid use or abuse of sedation to hasten the patient's death (described as "slow/passive euthanasia"). Objective: To evaluate the current practice of palliative sedation and use of opioids and sedatives at the end of life by using a registration document. Design: Retrospective observational study. Setting/Subjects: We included all in-hospital deaths at an academic hospital in Belgium of patients (age >= 18 years) who had received parenteral opioids, benzodiazepines, barbiturates, or other anesthetics during the last 24 hours. Measurements: We investigated indications for palliative sedation, patients' and physicians' characteristics, types of medication used, and the decision-making process with the patients and family. The questionnaires were collected between July 9 and November 25, 2016. The study was approved by the Biomedical Ethics Committee of UZ Brussel (B.U.N. 1432016293). Results: In a population of 124 patients, refractory symptoms were reported in 94.4%. All patients received parenteral opioids (intravenously). Benzodiazepines were used in 51.6%. In 75.8%, physicians reported no change in treatment plan during end of life. Hastening death by increasing analgesics and/or sedatives was mentioned in 19.3%. The treatment plan was discussed with patients in 26.6% of cases. In 6 cases, an explicit intention to hasten death was mentioned; in 36 cases, doses of opioids/sedatives may not have been strictly proportional to symptoms. Conclusion: This Belgian study shows that objective reporting of palliative sedation can be used as a tool to ensure good clinical practice where patients receive the most appropriate end-of-life care, avoiding abusive and injudicious or unskilled use of sedation.
引用
收藏
页码:742 / 748
页数:7
相关论文
共 50 条
  • [1] Belgian General Practitioners' Perspectives on the Use of Palliative Sedation in End-of-Life Home Care: A Qualitative Study
    Sercu, Maria
    Pype, Peter
    Christiaens, Thierry
    Derese, Anselme
    Deveugele, Myriam
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (06) : 1054 - 1063
  • [2] Palliative sedation in end-of-life care
    Maltoni, Marco
    Scarpi, Emanuela
    Nanni, Oriana
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (04) : 360 - 367
  • [3] Palliative Sedation at the End of Life: Patterns of Use in an Israeli Hospice
    Azoulay, Daniel
    Shahal-Gassner, Ruth
    Yehezkel, Malka
    Eliyahu, Ester
    Weigert, Nir
    Ein-Mor, Eliana
    Jacobs, Jeremy M.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2016, 33 (04) : 369 - 373
  • [4] Palliative sedation for delirium management at the end of life
    Roider-Schur, Sophie
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 93 - 97
  • [5] Palliative sedation at the end of life: prevalence, characteristics and possible determinants
    Carrasco-Zafra, Maria Isabel
    Ocana-Riola, Ricardo
    Gomez-Garcia, Rafael
    Martin-Rosello, Maria Luisa
    Blanco-Reina, Encarnacion
    BMC PALLIATIVE CARE, 2024, 23 (01):
  • [6] Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study
    Reuzel, R. P. B.
    Hasselaar, G. J.
    Vissers, K. C. P.
    van der Wilt, G. J.
    Groenewoud, J. M. M.
    Crul, B. J. P.
    PALLIATIVE MEDICINE, 2008, 22 (05) : 641 - 646
  • [7] At-home palliative sedation for end-of-life cancer patients
    Alonso-Babarro, Alberto
    Varela-Cerdeira, Maria
    Torres-Vigil, Isabel
    Rodriguez-Barrientos, Ricardo
    Bruera, Eduardo
    PALLIATIVE MEDICINE, 2010, 24 (05) : 486 - 492
  • [8] Continuous Deep Sedation in End-of-Life Care: a Retrospective Single-Center Study on the Use of Continuous Deep Sedation at the End of Life in a Palliative Care Unit in Switzerland
    Camartin, Cristian
    ZEITSCHRIFT FUR PALLIATIVMEDIZIN, 2019, 20 (04): : 181 - 186
  • [9] Palliative sedation at the end of life at a tertiary cancer center
    Caraceni, Augusto
    Zecca, Ernesto
    Martini, Cinzia
    Gorni, Giovanna
    Campa, Tiziana
    Brunelli, Cinzia
    De Conno, Franco
    SUPPORTIVE CARE IN CANCER, 2012, 20 (06) : 1299 - 1307
  • [10] Palliative sedation at end of life -: A systematic literature review
    Engstrom, Joakim
    Bruno, Erik
    Holm, Birgitta
    Hellzen, Ove
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2007, 11 (01) : 26 - 35